Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Interim Management Statement

7 Nov 2008 07:00

RNS Number : 6725H
Stanelco PLC
07 November 2008
 



7th November 2008

STANELCO PLC ("the Company" or "the Group")

Interim Management Statement

The Board of Stanelco Plc today issues its interim management statement for the nine month period ended 30 September 2008.

Overview

The first nine months of the year saw 120% growth in sales revenue to £12.2m compared with the same period last year (2007: £5.6m). We continued to make progress in reducing our operating losses.

Divisional Performance

BioPlastics

Commercialisation of the bioplastics technology continues as the Company broadens its base of regular customers, which is now developed across a variety of European markets.

Sales of bioplastics, made directly by Stanelcoare now up 450compared to the same 9 month period last year. Direct sales in the third quarter were up 24% on the second quarter, reaching £1.4m year-to-date.

In the third quarter the Company opened a small sales office in the USA to begin the process of exploiting the emerging opportunity for sustainable bioplastics in North America. This renewed activity is being driven by an experienced plastics industry professional and is already creating an encouraging pipeline of trials.

We have continued to strengthen the BioPlastics division in the UK by recruiting further senior technical and customer support expertise with substantive relevant expertise.  

Further minor investment in development and testing equipment was also made at the UK development facility in the period. Development trials continue to establish pace and laboratory success, with a number of new products having moved to pre-commercial trials with several customers.

RF Applications

In RF Applications divisionthe strong enquiry book is gradually being converted into orders and we expect to see some benefit of that in the second half as the General Manager and newly appointed Sales Manager begin to achieve traction.

The optical fiber furnace market continues to show encouraging signs, driven by continued fiber demand in Asia. In the third quarter, Stanelco continued to strengthen its position in China with its first order for its new generation of higher capacity furnaces powered by Stanelco's new RF generator.

There is also growing interest in the newly developed mobile welding products. However, the long lead times from enquiry to order mean that this is likely to have limited impact on this financial year's results.

Financial Position

We continue to maintain a strong balance sheet. Our cash position at 30 September was £6.9mstrengthened since the half year by working capital movements related to stock reduction.

Outlook 

Our strategy is clear and good progress is being made. We continue to look for compatible and sensible investment opportunities.

We remain alert to the rapidly changing economic conditions throughout the worldbut we have not seen an impact on our business as yet. The Board's expectations for the financial performance for 2008 remain in line with those set earlier in the year.

Ends -

Paul Mines, Chief Executive, Stanelco plc

Clive Warner, Finance Director, Stanelco plc

Tel: +44 (0) 2380 867 100

Jonathon Brill/Caroline Stewart

Financial Dynamics

Tel: +44 (0) 20 7831 3113

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBFBPTMMIMBBP
Date   Source Headline
27th Apr 20071:34 pmRNSResult of AGM
27th Apr 20071:32 pmRNSDirectorate Change
26th Apr 20071:42 pmRNSAnnual Information Update
13th Apr 200712:29 pmRNSDirector's Dealing
30th Mar 20071:32 pmRNSAnnual Report and Accounts
23rd Mar 20075:09 pmRNSNotifiable Interest
21st Mar 20077:03 amRNSPreliminary Results
14th Mar 20075:59 pmRNSHolding(s) in Company
26th Feb 20077:01 amRNSBoard Appointment
23rd Feb 20073:18 pmRNSHolding(s) in Company
30th Jan 20079:00 amRNSNotice of Results
18th Dec 20064:58 pmRNSTotal Voting Rights
8th Dec 200612:31 pmRNSNotifiable Interest
28th Nov 20063:32 pmRNSNotifiable Interest
17th Nov 20063:33 pmRNSNotifiable Interest
16th Nov 20069:02 amRNSNotifiable Interest
14th Nov 20064:37 pmRNSDirectorate Change
14th Nov 20064:09 pmRNSDirector/PDMR Shareholding
14th Nov 20064:03 pmRNSNotifiable Interest
14th Nov 20069:55 amRNSNotifiable Interest
10th Nov 200610:29 amRNSHolding(s) in Company
9th Nov 200611:45 amRNSNotifiable Interest
8th Nov 20063:08 pmRNSNotifiable Interest
7th Nov 20068:01 amRNSIssue of Equity
6th Nov 200612:12 pmRNSResult of EGM
3rd Nov 20064:41 pmRNSNotifiable Interest
3rd Nov 20061:17 pmRNSOpen Offer Result - Amendment
2nd Nov 20066:03 pmRNSOpen Offer Result
31st Oct 200611:54 amRNSNotifiable Interest
17th Oct 20065:54 pmRNSNotifiable Interest
17th Oct 200610:44 amRNSNotifiable Interest
16th Oct 20063:17 pmRNSNotifiable Interest
12th Oct 200612:35 pmRNSDoc re. Posting of Prospectus
11th Oct 20061:09 pmRNSNotifiable Interest
9th Oct 200611:13 amRNSProposed Placing & Open Offer
5th Oct 200610:25 amRNSFinancing Update
3rd Oct 200612:56 pmRNSStatement re. Press Comment
2nd Oct 20064:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20064:35 pmRNSPrice Monitoring Extension
8th Sep 20067:01 amRNSTrading Statement
17th Aug 20067:44 amRNSTrading Statement
16th Aug 20065:52 pmRNSAdditional Listing - AMEND
14th Aug 200611:55 amRNSAdditional Listing
10th Aug 200612:25 pmRNSRe Contract
14th Jul 20067:56 amRNSInterim Results - Replacement
14th Jul 20067:00 amRNSInterim Results
2nd Jun 200611:26 amRNSNew Ord Share Placing-Amendmt
2nd Jun 20068:45 amRNSNew Ordinary Share Placing
25th May 20067:02 amRNSWrap 100 FDA approval
16th May 200610:43 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.